• One pump daily dose conversion added to Oestrogel®SSPs

    The Department of Health and Social Care (DHSC) has updated Annex A of SSP022 and SSP023 for Oestrogel® Pump-Pack 0.06% gel to include a dose conversion to a specific alternative Estradiol patch for patients who use 1 pump of Oestrogel® daily. Previously, only dose conversions for patients using 2 to 4 pumps daily were included in Annex A of SSP022

    Read more
  • Over 10,700 contractors benefit from earlier advance payments on 12 May

    10,797 pharmacy contractors who declared their April 2022 FP34C submission figures through the Manage Your Service (MYS) portal by 6 May 2022 received their earlier advance payments on Thursday 12 May 2022 (circa 20 days earlier than the normal advance payment timetable). This leaves c.400 contractors who did not receive any earlier advance payments in

    Read more
  • NHSBSA reports of a rise in prescriptions returns due to incomplete endorsements

    NHSBSA reports of a rise in prescriptions returns due to incomplete endorsements

    The NHS Business Services Authority (NHSBSA) report seeing a rise in items that are being referred back (RB) to contractors for the reason code RB2B: ‘The order/endorsement is incomplete. The presentation must be present.’ The NHSBSA note that this issue is most commonly seen with handwritten prescriptions. Where prescription does not specify the presentation of a drug

    Read more
  • NHS prescription charges to remain at £9.35 per item until further notice

    The NHS prescription charge is reviewed annually with changes usually made in April, however, this year the Government has yet to conclude consideration of any future increases to prescription charges. Following our announcement that the NHS prescription charge would not be uplifted on 1 April 2022, a decision is yet to be reached on any

    Read more
  • Pharmacy Representation Review: PSNC Reaction to RSG Proposals  

    Pharmacy Representation Review: PSNC Reaction to RSG Proposals  

    The Review Steering Group (RSG) has published its proposals for the future of community pharmacy contractor representation and support. The proposals make 37 recommendations for the future of PSNC and the LPCs which the RSG says have been written to: Strengthen governance; Better align with the NHS; Appropriately resource representatives; and Strengthen collaboration. The RSG

    Read more
  • Reminder: Submit FP34C through MYS by 6 May for earlier advance payment

    With the early May bank holiday (2 May 2022) occurring in the first five days of the submission window contractors have an extra day (until the end of 6th of May) to submit their FP34C declaration through the Manage Your Service (MYS) portal for NHS pharmaceutical services delivered in April 2022. Contractors must also dispatch their

    Read more
  • Drug Tariff Watch – May 2022

    Drug Tariff Watch – May 2022

    The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2022. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. §

    Read more
  • Pharmacy Pressures Survey confirms impact on teams, businesses and patients

    PSNC’s Pharmacy Pressures Survey has confirmed that the unsustainable pressures on community pharmacies are having a serious impact on pharmacy teams’ wellbeing, affecting patient services negatively, and putting businesses at risk. The survey of over 5,000 pharmacy premises and 1,000 pharmacy team members took place in early 2022, asking community pharmacy contractors and, separately, pharmacy

    Read more
  • April 2022 Price Concessions 2nd Update

    The Department of Health and Social Care (DHSC) has today (21/04/2022) granted the following list of price concessions: Drug Pack size Price Concession Amoxicillin 250mg/5ml oral suspension sugar free 100 £1.40 Baclofen 5mg/5ml oral solution sugar free 300 £2.29 Bisacodyl 10mg suppositories 12 £2.49 Chlorpromazine 50mg tablets 28 £10.24 Co-dydramol 10mg/500mg tablets 100 £7.63 Co-dydramol

    Read more
  • MHRA Drug Safety Update April 2022

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 9 April 2022) has been published and includes articles on: Pregabalin (Lyrica): findings of safety study on risks during pregnancy COVID-19 vaccines and medicines: updates for April 2022 Letters and medicine recalls sent to healthcare professionals in January 2022 To

    Read more
Generated by Feedzy